申请人:Pfizer Inc.
公开号:US04448781A1
公开(公告)日:1984-05-15
The N-(substituted benzyl) imidazoles are selective enzyme inhibitors and thus are useful in the treatment of heart disease, circulatory and vascular problems.
N-(取代苄基)咪唑是选择性酶抑制剂,因此在治疗心脏病、循环系统问题和血管问题方面很有用。